160 related articles for article (PubMed ID: 37679334)
21. Crystal structures of the TRAF2: cIAP2 and the TRAF1: TRAF2: cIAP2 complexes: affinity, specificity, and regulation.
Zheng C; Kabaleeswaran V; Wang Y; Cheng G; Wu H
Mol Cell; 2010 Apr; 38(1):101-13. PubMed ID: 20385093
[TBL] [Abstract][Full Text] [Related]
22. XIAP Loss Triggers RIPK3- and Caspase-8-Driven IL-1β Activation and Cell Death as a Consequence of TLR-MyD88-Induced cIAP1-TRAF2 Degradation.
Lawlor KE; Feltham R; Yabal M; Conos SA; Chen KW; Ziehe S; Graß C; Zhan Y; Nguyen TA; Hall C; Vince AJ; Chatfield SM; D'Silva DB; Pang KC; Schroder K; Silke J; Vaux DL; Jost PJ; Vince JE
Cell Rep; 2017 Jul; 20(3):668-682. PubMed ID: 28723569
[TBL] [Abstract][Full Text] [Related]
23. TRAF2 suppresses basal IKK activity in resting cells and TNFalpha can activate IKK in TRAF2 and TRAF5 double knockout cells.
Zhang L; Blackwell K; Thomas GS; Sun S; Yeh WC; Habelhah H
J Mol Biol; 2009 Jun; 389(3):495-510. PubMed ID: 19409903
[TBL] [Abstract][Full Text] [Related]
24. Allosteric regulation of the ubiquitin:NIK and ubiquitin:TRAF3 E3 ligases by the lymphotoxin-beta receptor.
Sanjo H; Zajonc DM; Braden R; Norris PS; Ware CF
J Biol Chem; 2010 May; 285(22):17148-55. PubMed ID: 20348096
[TBL] [Abstract][Full Text] [Related]
25. TRAF2-binding BIR1 domain of c-IAP2/MALT1 fusion protein is essential for activation of NF-kappaB.
Garrison JB; Samuel T; Reed JC
Oncogene; 2009 Apr; 28(13):1584-93. PubMed ID: 19234489
[TBL] [Abstract][Full Text] [Related]
26. A Complex Relationship between TRAF3 and Non-Canonical NF-κB2 Activation in B Lymphocytes.
Lin WW; Hildebrand JM; Bishop GA
Front Immunol; 2013; 4():477. PubMed ID: 24391649
[TBL] [Abstract][Full Text] [Related]
27. TRAF interactions with raft-like buoyant complexes, better than TRAF rates of degradation, differentiate signaling by CD40 and EBV latent membrane protein 1.
Ardila-Osorio H; Pioche-Durieu C; Puvion-Dutilleul F; Clausse B; Wiels J; Miller W; Raab-Traub N; Busson P
Int J Cancer; 2005 Jan; 113(2):267-75. PubMed ID: 15386359
[TBL] [Abstract][Full Text] [Related]
28. Both amino- and carboxyl-terminal domains of TRAF3 negatively regulate NF-kappaB activation induced by OX40 signaling.
Takaori-Kondo A; Hori T; Fukunaga K; Morita R; Kawamata S; Uchiyama T
Biochem Biophys Res Commun; 2000 Jun; 272(3):856-63. PubMed ID: 10860842
[TBL] [Abstract][Full Text] [Related]
29. Rescue of TRAF3-null mice by p100 NF-kappa B deficiency.
He JQ; Zarnegar B; Oganesyan G; Saha SK; Yamazaki S; Doyle SE; Dempsey PW; Cheng G
J Exp Med; 2006 Oct; 203(11):2413-8. PubMed ID: 17015635
[TBL] [Abstract][Full Text] [Related]
30. TRAF2 phosphorylation modulates tumor necrosis factor alpha-induced gene expression and cell resistance to apoptosis.
Blackwell K; Zhang L; Thomas GS; Sun S; Nakano H; Habelhah H
Mol Cell Biol; 2009 Jan; 29(2):303-14. PubMed ID: 18981220
[TBL] [Abstract][Full Text] [Related]
31. TRAF2 regulates peripheral CD8(+) T-cell and NKT-cell homeostasis by modulating sensitivity to IL-15.
Villanueva JE; Malle EK; Gardam S; Silveira PA; Zammit NW; Walters SN; Brink R; Grey ST
Eur J Immunol; 2015 Jun; 45(6):1820-31. PubMed ID: 25931426
[TBL] [Abstract][Full Text] [Related]
32. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.
Keats JJ; Fonseca R; Chesi M; Schop R; Baker A; Chng WJ; Van Wier S; Tiedemann R; Shi CX; Sebag M; Braggio E; Henry T; Zhu YX; Fogle H; Price-Troska T; Ahmann G; Mancini C; Brents LA; Kumar S; Greipp P; Dispenzieri A; Bryant B; Mulligan G; Bruhn L; Barrett M; Valdez R; Trent J; Stewart AK; Carpten J; Bergsagel PL
Cancer Cell; 2007 Aug; 12(2):131-44. PubMed ID: 17692805
[TBL] [Abstract][Full Text] [Related]
33. Specificity of TRAF3 in its negative regulation of the noncanonical NF-kappa B pathway.
He JQ; Saha SK; Kang JR; Zarnegar B; Cheng G
J Biol Chem; 2007 Feb; 282(6):3688-94. PubMed ID: 17158868
[TBL] [Abstract][Full Text] [Related]
34. TRAF2 must bind to cellular inhibitors of apoptosis for tumor necrosis factor (tnf) to efficiently activate nf-{kappa}b and to prevent tnf-induced apoptosis.
Vince JE; Pantaki D; Feltham R; Mace PD; Cordier SM; Schmukle AC; Davidson AJ; Callus BA; Wong WW; Gentle IE; Carter H; Lee EF; Walczak H; Day CL; Vaux DL; Silke J
J Biol Chem; 2009 Dec; 284(51):35906-15. PubMed ID: 19815541
[TBL] [Abstract][Full Text] [Related]
35. TRAF2 differentially regulates the canonical and noncanonical pathways of NF-kappaB activation in mature B cells.
Grech AP; Amesbury M; Chan T; Gardam S; Basten A; Brink R
Immunity; 2004 Nov; 21(5):629-42. PubMed ID: 15539150
[TBL] [Abstract][Full Text] [Related]
36. Birinapant (TL32711), a bivalent SMAC mimetic, targets TRAF2-associated cIAPs, abrogates TNF-induced NF-κB activation, and is active in patient-derived xenograft models.
Benetatos CA; Mitsuuchi Y; Burns JM; Neiman EM; Condon SM; Yu G; Seipel ME; Kapoor GS; Laporte MG; Rippin SR; Deng Y; Hendi MS; Tirunahari PK; Lee YH; Haimowitz T; Alexander MD; Graham MA; Weng D; Shi Y; McKinlay MA; Chunduru SK
Mol Cancer Ther; 2014 Apr; 13(4):867-79. PubMed ID: 24563541
[TBL] [Abstract][Full Text] [Related]
37. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation.
Devergne O; Hatzivassiliou E; Izumi KM; Kaye KM; Kleijnen MF; Kieff E; Mosialos G
Mol Cell Biol; 1996 Dec; 16(12):7098-108. PubMed ID: 8943365
[TBL] [Abstract][Full Text] [Related]
38. Proteasomal Degradation of TRAF2 Mediates Mitochondrial Dysfunction in Doxorubicin-Cardiomyopathy.
Dhingra R; Rabinovich-Nikitin I; Rothman S; Guberman M; Gang H; Margulets V; Jassal DS; Alagarsamy KN; Dhingra S; Valenzuela Ripoll C; Billia F; Diwan A; Javaheri A; Kirshenbaum LA
Circulation; 2022 Sep; 146(12):934-954. PubMed ID: 35983756
[TBL] [Abstract][Full Text] [Related]
39. Pro-apoptotic functions of TRAF2 in p53-mediated apoptosis induced by cisplatin.
Tsuchida M; Yokosawa T; Noguchi T; Shimada T; Yamada M; Sekiguchi Y; Hirata Y; Matsuzawa A
J Toxicol Sci; 2020; 45(4):219-226. PubMed ID: 32238696
[TBL] [Abstract][Full Text] [Related]
40. TRAF2 phosphorylation promotes NF-κB-dependent gene expression and inhibits oxidative stress-induced cell death.
Zhang L; Blackwell K; Altaeva A; Shi Z; Habelhah H
Mol Biol Cell; 2011 Jan; 22(1):128-40. PubMed ID: 21119000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
